Vitamin D Dose Finding Study

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT01092338

First Posted: March 24, 2010

Last Update Posted: September 18, 2013

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborators:

National Institutes of Health (NIH)

National Center for Complementary and Integrative Health (NCCIH)

Information provided by (Responsible Party):

Children's Hospital of Philadelphia

Results First Submitted: January 7, 2013

Study Type:	Interventional
Study Design:	Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment
Conditions:	HIV Infections AIDS
Intervention:	Drug: Cholecalciferol (Vit D3)

Participant Flow

Show Participant Flow

Baseline Characteristics

Hide Baseline Characteristics

Population Description

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups

	Description
4000IU/d of Vitamin D3	No text entered.
7000IU/d Vitamin D3	No text entered.
Total	Total of all reporting groups

Baseline Measures

	4000IU/d of Vitamin D3	7000IU/d Vitamin D3	Total
Overall Participants Analyzed [Units: Participants]	22	22	44

Age [Units: Participants]
<=18 years	9	7	16
Between 18 and 65 years	13	15	28
>=65 years	0	0	0

Age [Units: Years] Mean (Standard Deviation)	18.4 (4.5)	19.1 (5.0)	18.7 (4.7)

Gender [Units: Participants]
Female	7	7	14
Male	15	15	30

Region of Enrollment [Units: Participants]
United States	22	22	44